Importance of Pediatric Inclusion in COVID-19 Therapeutic Trials.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 32459832.
- Also identified by DOI 10.1093/cid/ciaa656 and PMC identifier 7314177.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Pediatric patients are excluded from most coronavirus disease 2019 (COVID-19) therapeutic trials. We outline a rationale for the inclusion of children in COVID-19 therapeutic trials, which enabled us to include children of all ages in a therapeutic COVID-19 trial at our institution.
Medical subject headings
- COVID-19
- Clinical Trials as Topic
- Coronavirus Infections
- COVID-19 Drug Treatment